Carfilzomib intermediate-1

[868540-16-3]

12352005

H302, H315, H319, H335

Drug Intermediate

Others

Cancer-programmed cell death

Cancer

98.15

OC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@H](CCC2=CC=CC=C2)NC(CN3CCOCC3)=O)=O)CC(C)C)=O)=O

C31H42N4O6

566.69

H302, H315, H319, H335

[1] Huang Chun, et al. Hydrogenation method of carfilzomib intermediate. Patent. CN117247426

Room Temperature

-20°C, 3 years; 4°C, 2 years (Powder)

Reference compound1

No Development Reported